Overall read
Do not stack casually
Synergy: 2Avoid: 1Unknown: 3
Selected: Tirzepatide, Semaglutide, 5-Amino-1MQ, AOD-9604. This is a triage layer, not a dosing or safety clearance.
Interaction intelligence
Stack Interaction Checker
Select up to eight compounds and review known synergies, redundancies, cautions, and unknowns. Unknown is shown honestly instead of guessed.
This tool shows known and theoretical relationships from published research and community practice. It does not constitute medical advice. Always consult a qualified healthcare provider.
Tirzepatide + Semaglutide
AvoidBoth compounds use GLP-1 receptor activity; tirzepatide adds GIP agonism but still overlaps semaglutide on appetite, gastric-emptying, and incretin adverse-effect pathways.
Confidence: mechanistic · Evidence: Class-overlap pharmacology and prescribing logic; not a recommended community stack.
Caution: Do not combine without clinician direction. Watch overlapping nausea, dehydration risk, gallbladder/pancreatitis warning context, and hypoglycemia risk when other glucose-lowering drugs are involved.
Source/rationale: GLP-1/GIP receptor-class pharmacology
Tirzepatide + 5-Amino-1MQ
Synergy5-Amino-1MQ + GLP-1 medications (semaglutide, tirzepatide): community metabolic optimization stack; GLP-1 addresses appetite/insulin; 5-Amino-1MQ addresses NAD+/adipocyte metabolism; mechanistically complementary; no interaction concerns documented.
Confidence: mechanistic · Evidence: Documented in the 5-Amino-1MQ chapter's stacking discussion (community/mechanistic, not a controlled combination trial).
Source/rationale: chapter:amq §9
Tirzepatide + AOD-9604
UnknownNo interaction data — community use appears common but no published data exists for this combination.
Confidence: unknown · Evidence: No pair-specific source/rationale in the current interaction dataset.
Source/rationale: Fallback: unknown pair
Semaglutide + 5-Amino-1MQ
Synergy5-Amino-1MQ + GLP-1 medications (semaglutide, tirzepatide): community metabolic optimization stack; GLP-1 addresses appetite/insulin; 5-Amino-1MQ addresses NAD+/adipocyte metabolism; mechanistically complementary; no interaction concerns documented.
Confidence: mechanistic · Evidence: Documented in the 5-Amino-1MQ chapter's stacking discussion (community/mechanistic, not a controlled combination trial).
Source/rationale: chapter:amq §9
Semaglutide + AOD-9604
UnknownNo interaction data — community use appears common but no published data exists for this combination.
Confidence: unknown · Evidence: No pair-specific source/rationale in the current interaction dataset.
Source/rationale: Fallback: unknown pair
5-Amino-1MQ + AOD-9604
UnknownNo interaction data — community use appears common but no published data exists for this combination.
Confidence: unknown · Evidence: No pair-specific source/rationale in the current interaction dataset.
Source/rationale: Fallback: unknown pair